BEAM vs LCTX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LCTX Captures Institutional Edge (3โ1 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Lineage Cell Therapeutics, Inc. (LCTX) driven by superior Valuation, Growth & Margin, Momentum & Technical while BEAM counters with relative strength in Options & Structure. Fundamentally, BEAM trades at N/M Forward P/E with -267.7% operating margin (-96.8% YoY revenue) versus LCTX at 30.7x Forward P/E and -280.3% operating margin (-61.0% YoY). In options structure, BEAM sits in BREAKDOWN (19th %ile IV; Dealer Gamma Walls on Pro) against LCTX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | BEAM Revenue | LCTX Revenue | BEAM Op. Margin | LCTX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | -837.9% | LCTX |
| FY2019 | $0M | $0M | -417522.2% | -1106.0% | LCTX |
| FY2020 | $0M | $0M | -553166.7% | -1448.4% | LCTX |
| FY2021 | $50M | $0M | -757.0% | -1133.6% | BEAM |
| FY2022 | $60M | $10M | -555.6% | -153.2% | LCTX |
| FY2023 | $380M | $10M | -46.7% | -276.5% | BEAM |
| FY2024 | $60M | $10M | -654.3% | -226.1% | LCTX |
| FY2025 | $140M | $10M | -274.6% | -251.6% | LCTX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BEAM | LCTX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $2.2B | $212.1M | Larger Scale | BEAM |
| Trailing P/E Ratio Valuation | N/M | 30.7x | Lower Multiple | LCTX |
| Forward P/E Ratio Valuation | N/M | 30.7x | Lower Multiple | LCTX |
| Revenue Growth (YoY) Growth | -96.8% | -61.0% | Higher Growth | LCTX |
| Operating Margin (TTM) Profitability | -267.7% | -280.3% | Higher Margin | BEAM |
| Net Profit Margin Profitability | -73.9% | 16.2% | Higher Margin | LCTX |
| Return on Equity (ROE) Capital Efficiency | -11.3% | 4.3% | Higher ROE | LCTX |
| 52-Week Range Position Momentum | 4% ($20โ$38) | 4% ($1โ$2) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 2.24ฮฒ ยท 86% Vol | 1.36ฮฒ ยท 79% Vol | Lower Realized Risk | LCTX |
| Unified Institutional Score Composite Signal | 57.3 / 100 (HOLD) | 58.9 / 100 (HOLD) | Higher Composite | LCTX |